Lift Biosciences
Agent58Agent Readiness: 58/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust68Data Trust: 68/100. Above median. Measured by StartupHub.ai. Median 61.Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
LIfT BioSciences is a UK-based biotechnology company developing first-in-class, off-the-shelf neutrophil-lineage cell therapies called Immunomodulatory Alpha Neutrophils (IMANs). These therapies are designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients with solid tumors. LIfT BioSciences is preparing for its first-in-human clinical study to assess IMANs' safety and efficacy in patients with advanced cervical and head & neck cancers.
Also in this space
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Shares Biotech, MedTech
Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
Shares Biotech, MedTech
Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Shares Biotech, MedTech
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
Gene therapy company developing transformative treatments for severe genetic diseases.
Shares Biotech, MedTech
Key facts
- Website
- liftbiosciences.com
- Headquarters
- Cambridge, United Kingdom
- Founded
- 2019
- Employees
- 22
- Total funding
- $18M
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 29 Jul 2025 | Undisclosed round | $13M | European Innovation Council (EIC) Accelerator, Horizon Europe |
| 1 Mar 2021 | Undisclosed round | $5M | Astellas Venture Management |
Tech stack
Detected on liftbiosciences.com, last scanned 11 Aug 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- Email provider
- Microsoft 365
Lift Biosciences scores 24. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Lift Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Lift Biosciences is 68 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Lift Biosciences raised?
Lift Biosciences has raised a total of $18M in funding.
How many employees does Lift Biosciences have?
Lift Biosciences has approximately 22 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Lift Biosciences
